[go: up one dir, main page]

LT3890767T - Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui - Google Patents

Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui

Info

Publication number
LT3890767T
LT3890767T LTEPPCT/EP2019/083470T LTEP2019083470T LT3890767T LT 3890767 T LT3890767 T LT 3890767T LT EP2019083470 T LTEP2019083470 T LT EP2019083470T LT 3890767 T LT3890767 T LT 3890767T
Authority
LT
Lithuania
Prior art keywords
treatment
lung diseases
inhalation compositions
inhalation
compositions
Prior art date
Application number
LTEPPCT/EP2019/083470T
Other languages
English (en)
Inventor
Oliver Denk
Original Assignee
Breath Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Breath Therapeutics Gmbh filed Critical Breath Therapeutics Gmbh
Publication of LT3890767T publication Critical patent/LT3890767T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0005Details of inhalators; Constructional features thereof with means for agitating the medicament
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0018Details of inhalators; Constructional features thereof with exhalation check valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0085Inhalators using ultrasonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/EP2019/083470T 2018-12-04 2019-12-03 Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui LT3890767T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18210255 2018-12-04
PCT/EP2019/083470 WO2020115032A1 (en) 2018-12-04 2019-12-03 Inhalable compositions for use in the treatment of pulmonary diseases

Publications (1)

Publication Number Publication Date
LT3890767T true LT3890767T (lt) 2022-12-12

Family

ID=64606777

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2019/083470T LT3890767T (lt) 2018-12-04 2019-12-03 Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui

Country Status (23)

Country Link
US (4) US11419819B2 (lt)
EP (1) EP3890767B1 (lt)
JP (1) JP7285930B2 (lt)
KR (1) KR102475644B1 (lt)
CN (3) CN113164553B (lt)
AU (1) AU2019392626B2 (lt)
BR (1) BR112021010756A2 (lt)
CA (1) CA3121362C (lt)
CO (1) CO2021007141A2 (lt)
EA (2) EA202092892A1 (lt)
ES (1) ES2932966T3 (lt)
FI (1) FI3890767T3 (lt)
HR (1) HRP20221529T1 (lt)
HU (1) HUE060322T2 (lt)
IL (1) IL283469B (lt)
LT (1) LT3890767T (lt)
MX (1) MX393654B (lt)
PL (1) PL3890767T3 (lt)
PT (1) PT3890767T (lt)
RS (1) RS63847B1 (lt)
SI (1) SI3890767T1 (lt)
SM (1) SMT202200482T1 (lt)
WO (1) WO2020115032A1 (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069711A1 (en) * 2015-03-16 2016-09-21 PARI Pharma GmbH Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
GB202009252D0 (en) * 2020-06-17 2020-07-29 Nicoventures Trading Ltd Non-combustible aerosol delivery system, filter unit and assmebly
US20230330357A1 (en) * 2020-09-22 2023-10-19 Avalyn Pharma Inc. Nebulizer device optimization for improved aerosol parameters and uses thereof
EP4249022A1 (en) * 2022-03-21 2023-09-27 PARI Pharma GmbH Drug-device combination
CN115006656A (zh) * 2022-05-18 2022-09-06 苏州易合医药有限公司 一种可连续提供肺部活性剂粉雾剂的给药装置
EP4464353A1 (en) * 2023-05-15 2024-11-20 PARI Pharma GmbH Inhalation therapy device
EP4520374A1 (en) * 2023-09-07 2025-03-12 DelBio, Inc. Nebulization medicament delivery device
CN119607332A (zh) * 2024-12-03 2025-03-14 深圳雾芯科技有限公司 雾化系统、雾化方法、吸入溶液、药液仓和组合产品

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857319A (en) 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5958378A (en) * 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
TW497974B (en) 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
IT1289938B1 (it) 1997-02-20 1998-10-19 Angelini Ricerche Spa Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
EP1126890A4 (en) * 1998-11-06 2003-08-13 Salter Labs MOUTHPIECE AND ACCESSORIES FOR NEBULIZER
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
DE10102846B4 (de) 2001-01-23 2012-04-12 Pari Pharma Gmbh Aerosolgenerator
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
US7452524B2 (en) * 2004-01-27 2008-11-18 Gilead Sciences, Inc. Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
CA2584583A1 (en) * 2004-10-28 2006-05-11 Alza Corporation Lyophilized liposome formulations and method
DE102005038619A1 (de) 2005-08-16 2007-02-22 Pari GmbH Spezialisten für effektive Inhalation Inhalationstherapievorrichtung mit einer Ampulle für die Bevorratung eines zu vernebelnden Medikaments
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
WO2007067784A2 (en) 2005-12-08 2007-06-14 Wyeth Liposomal compositions
EP1927373B1 (en) 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
PL2285439T3 (pl) 2008-04-04 2014-05-30 Nektar Therapeutics Urządzenie do przeprowadzania w aerozol
CA2808836C (en) * 2010-08-23 2020-05-12 Darren Rubin Systems and methods of aerosol delivery with airflow regulation
EP3795361A1 (en) * 2010-12-28 2021-03-24 Stamford Devices Limited Photodefined aperture plate and method for producing the same
EP4331675A3 (en) * 2012-05-21 2024-05-29 Insmed Incorporated Systems for treating pulmonary infections
US9677919B2 (en) 2014-11-26 2017-06-13 Rosemount Inc. Gauge display system
EP3069711A1 (en) * 2015-03-16 2016-09-21 PARI Pharma GmbH Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
US9566399B1 (en) * 2015-04-14 2017-02-14 Clempharma LLC Deep lung alveolar aerosol targeted drug delivery

Also Published As

Publication number Publication date
US20220023211A1 (en) 2022-01-27
US11890376B2 (en) 2024-02-06
CN113164553B (zh) 2023-04-21
PT3890767T (pt) 2022-11-29
PL3890767T3 (pl) 2023-05-08
MX2021006585A (es) 2022-07-04
SI3890767T1 (sl) 2023-02-28
US20240122852A1 (en) 2024-04-18
CA3121362A1 (en) 2020-06-11
AU2019392626A1 (en) 2021-06-24
KR102475644B1 (ko) 2022-12-07
MX393654B (es) 2025-03-12
CN116726146A (zh) 2023-09-12
SMT202200482T1 (it) 2023-01-13
IL283469B (en) 2022-07-01
HRP20221529T1 (hr) 2023-02-17
HUE060322T2 (hu) 2023-02-28
US11419819B2 (en) 2022-08-23
KR20210110312A (ko) 2021-09-07
JP7285930B2 (ja) 2023-06-02
EP3890767B1 (en) 2022-10-12
US20220347098A1 (en) 2022-11-03
FI3890767T3 (fi) 2023-01-13
US12263247B2 (en) 2025-04-01
RS63847B1 (sr) 2023-01-31
CO2021007141A2 (es) 2021-08-19
CN113164553A (zh) 2021-07-23
ES2932966T3 (es) 2023-01-30
CA3121362C (en) 2024-01-02
AU2019392626B2 (en) 2022-02-10
EA202092892A1 (ru) 2021-05-27
WO2020115032A1 (en) 2020-06-11
JP2022510953A (ja) 2022-01-28
IL283469A (en) 2021-07-29
EA202191307A1 (ru) 2021-08-09
US20250241855A1 (en) 2025-07-31
CN116688093A (zh) 2023-09-05
BR112021010756A2 (pt) 2021-08-31
EP3890767A1 (en) 2021-10-13

Similar Documents

Publication Publication Date Title
LT3890767T (lt) Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui
IL281093A (en) Combinations for treatment of nash/nafld and related diseases
EP3513667A4 (en) Flavor inhaler
EP3440948A4 (en) GESCHMACKSINHALATOR
LT3496739T (lt) Kompozicijos ir būdai, skirti plaučių hipertenzijai gydyti
PL3672954T3 (pl) Związki, ich sole i ich zastosowanie w leczeniu chorób
EP3400815A4 (en) GESCHMACKSINHALATOR
EA201790273A1 (ru) Флагеллиновые композиции и их применение
IL273169A (en) A new combination of active substances for the treatment of advanced interstitial and lymphoid lung diseases
PT3481846T (pt) 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda
SG11202000893QA (en) Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
EP3636305A4 (en) MEDICAL NEBULIZER
EP3927405A4 (en) ADJUSTABLE EXPIRATORY RELIEF IN RESPIRATORY THERAPY
IL283453A (en) Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
WO2015179823A8 (en) Lung localized inhibitors of alpha(v)beta 6
DK3476395T3 (da) Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme
EP3918931A4 (en) FLAVOR INHALER
SG11202010585WA (en) New treatment of interstitial lung diseases
EP3443854A4 (en) GESCHMACKSINHALATOR
EP3927328A4 (en) INHALABLE THERAPEUTIC AGENT
LT3124048T (lt) Kompozicija skirta vartoti per burną gastroezofaginio refliukso ligos ar skausmo gydymui
IT201700109080A1 (it) Composizione per la prevenzione e/o il trattamento delle affezioni delle vie respiratorie
LT3458045T (lt) Ebselenas, skirtas naudoti menjero ligos gydymui
DK3761982T3 (da) Anvendelse af nalfurafin til behandling af demyeliniserende sygdomme
ES3049333T3 (en) Compounds for the treatment of respiratory diseases